1. Home
  2. BIO vs GTLS Comparison

BIO vs GTLS Comparison

Compare BIO & GTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • GTLS
  • Stock Information
  • Founded
  • BIO 1952
  • GTLS 1859
  • Country
  • BIO United States
  • GTLS United States
  • Employees
  • BIO N/A
  • GTLS N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • GTLS Metal Fabrications
  • Sector
  • BIO Industrials
  • GTLS Industrials
  • Exchange
  • BIO Nasdaq
  • GTLS Nasdaq
  • Market Cap
  • BIO 7.7B
  • GTLS 9.0B
  • IPO Year
  • BIO N/A
  • GTLS 1992
  • Fundamental
  • Price
  • BIO $282.38
  • GTLS $199.38
  • Analyst Decision
  • BIO Strong Buy
  • GTLS Buy
  • Analyst Count
  • BIO 4
  • GTLS 14
  • Target Price
  • BIO $333.50
  • GTLS $200.50
  • AVG Volume (30 Days)
  • BIO 229.1K
  • GTLS 1.5M
  • Earning Date
  • BIO 10-29-2025
  • GTLS 10-31-2025
  • Dividend Yield
  • BIO N/A
  • GTLS N/A
  • EPS Growth
  • BIO N/A
  • GTLS 176.90
  • EPS
  • BIO 11.49
  • GTLS 5.39
  • Revenue
  • BIO $2,554,200,000.00
  • GTLS $4,253,100,000.00
  • Revenue This Year
  • BIO $2.12
  • GTLS $12.49
  • Revenue Next Year
  • BIO $2.90
  • GTLS $9.94
  • P/E Ratio
  • BIO $24.57
  • GTLS $37.00
  • Revenue Growth
  • BIO N/A
  • GTLS 8.95
  • 52 Week Low
  • BIO $211.43
  • GTLS $104.60
  • 52 Week High
  • BIO $387.99
  • GTLS $220.03
  • Technical
  • Relative Strength Index (RSI)
  • BIO 51.63
  • GTLS 65.06
  • Support Level
  • BIO N/A
  • GTLS $198.71
  • Resistance Level
  • BIO $298.00
  • GTLS $200.00
  • Average True Range (ATR)
  • BIO 7.29
  • GTLS 0.70
  • MACD
  • BIO -12.88
  • GTLS -0.78
  • Stochastic Oscillator
  • BIO 93.86
  • GTLS 69.46

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About GTLS Chart Industries Inc.

Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.

Share on Social Networks: